JBIO CIK: 1798749

Jade Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−27.4
FY22:
−39.1
FY23:
−56.8
FY24:
−71.2
FY25:
−94.7
Change from FY21 to FY25
millions USD
FY21:
−113
FY22:
6.93
FY23:
11.9
FY24:
56.0
FY25:
−247
Change from FY21 to FY25
millions USD
FY21:
190
FY22:
0.40
FY23:
46.0
FY24:
25.4
FY25:
361
millions USD
FY21:
49.6
FY22:
−31.8
FY23:
1.09
FY24:
10.3
FY25:
19.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−27.6
FY22:
−39.3
FY23:
−56.9
FY24:
–
FY25:
−94.9

All amounts in millions USD Data source:SEC EDGAR